HealthRX.com · Printable titration log
Ozempic 0.5 mg injection to semaglutide tablets: switch-week and morning-dose record
Use this from the last injection through the first weeks of tablets: the dates that set the switch, the tablet the pharmacy actually dispensed, and a morning-by-morning check of the dosing routine the label ties absorption to.
The switch dates
Ozempic injection dose before switchingthe label route is from 0.5 mg
Date of the last injection
Planned date of the first tablet
Tablet dispensed: product name and strengthcopy it from the bottle
Insulin or sulfonylurea also taken?
The label's switch options from the 0.5 mg injection[1]
| Tablet product | Start one week after the last 0.5 mg injection |
|---|---|
| Rybelsus | 7 mg or 14 mg once daily |
| Ozempic tablets | 4 mg or 9 mg once daily |
Morning dose check
Tick each morning for the first weeks; a missed tablet is skipped, not doubled.
| Date | Tablet taken on waking, empty stomach? | Water used (no more than 4 oz) | Minutes before first food, drink or pills | Swallowed whole? | Nausea, vomiting or diarrhea | Glucose reading |
|---|---|---|---|---|---|---|
Label points behind the record
- Take one tablet each morning on an empty stomach with up to 4 ounces of water, then wait at least 30 minutes before food, drinks or other medicines.[1]
- Swallow the tablet whole; if a dose is missed, skip it and take the next one the following day.[1]
- Tablet levels reach steady state after 4 to 5 weeks of daily dosing.[1]
- Semaglutide from the injections stays in circulation for about 5 weeks after the last one.[2]
- Tablet strengths are not interchangeable milligram for milligram.[1]
Questions before and after the switch
- My injection dose is not 0.5 mg: what plan do you want me to follow?
- Which tablet and strength am I starting, and is that what the pharmacy gave me?
- When should we recheck A1c after the change?
- Should my insulin or sulfonylurea change while the tablets build up?
Sources for the facts on this sheet
- Novo Nordisk, via DailyMed. Rybelsus (semaglutide) tablets and Ozempic (semaglutide) tablets, for oral use: prescribing information and Medication Guide. Effective 2026-01-30. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98
- Novo Nordisk, via DailyMed. Ozempic (semaglutide) injection, for subcutaneous use: prescribing information and Medication Guide. Effective 2026-06-01. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.